Article
Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.
The American Journal of dermatopathology - 1 Apr 2019
Thomas Nancy E, Edmiston Sharon N, Tsai Yihsuan S, Parker Joel S, Googe Paul B, Busam Klaus J, Scott Glynis A, Zedek Daniel C, Parrish Eloise A, Hao Honglin, Slater Nathaniel A, Pearlstein Michelle V, Frank Jill S, Kuan Pei Fen, Ollila David W, Conway Kathleen
Abstract excerpt
Telomerase reverse transcriptase (TERT) promoter mutations are commonly found in malignant melanomas but rare in melanocytic nevi. To assess its potential diagnostic utility for the distinction of melanoma from nevus, we determined the TERT promoter mutation status of 86 primary melanomas, 72 melanocytic nevi, and 40 diagnostically problematic melanocytic proliferations. Of the 86 melanomas, 67 (77.9%) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
